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Screening, Brief Intervention and Referral to Treatment (SBIRT): 1 
A Nursing Perspective 2 
 3 
Introduction 4 
 5 
 Screening, brief intervention and referral to treatment (SBIRT) was first initiated by the 6 
World Health Organization (WHO) in the mid 1980’s in recognition of alcohol as an important 7 
contributor of ill health, mental health issues, injuries from trauma, and social problems .1 For 8 
example, in 2002, 3.2% of deaths worldwide were attributed to alcohol use.1 SBIRT has been 9 
successfully implemented in primary care and emergency departments and globally.1-11 In 10 
emergency medicine, SBIRT has been mandated by the American College of Surgeons 11 
Committee on Trauma for all Level I trauma centers in the United States.8  There are a few 12 
studies, however, with results that question the efficacy of SBIRT to reduce alcohol use at longer 13 
term, at 12 months of follow-up. 7, 9-10  14 
Advantages and challenges of SBIRT  15 
 Advantages of SBIRT include: 16 
1. Flexibility in its implementation 17 
2. Simple screening  18 
3. Raising awareness in general among all alcohol users 19 
4. Allowing for data collection on the extent of alcohol use 20 
5. Contribution to larger public health implications of alcohol use 21 
6. Potential cost-savings and positive return on investment 22 
 23 
The flexibility of the SBIRT allows its components to be molded for local needs from choosing 24 
the appropriate screening test to defining the most efficient way to conduct the brief intervention.  25 
Screenings have been effectively conducted by different levels of providers either by 26 
incorporating the screening in the larger health assessment or by approaching the topic of alcohol 27 
use separately.2-11  Similarly, brief intervention can be conducted following the screening or done 28 
outside of the visit through coordination with other providers . The advantage of screening using 29 
motivational interviewing is that it has been found to raise overall awareness on alcohol use as 30 
seen in the drop in alcohol use by controls in the short-term.4,6-8,11 31 
 The most important contribution to SBIRT is that universal screening allows for the 32 
collection of data on the extent of alcohol use in a community in the form of a needs assessment. 33 
With this data, public health policies can be more effectively taylored to the needs of the 34 
community. The power of information can also apply political pressure to fund preventive care 35 
versus shifting the money towards expensive down-stream care of trauma and chronic medical 36 
issues directly caused by alcohol use. 37 
 Among the challenges in SBIRT are 38 
 39 
1. The flexibility in the interpretation of the components 40 
2. Long-term efficacy 41 
3. Staff buy-in of the concepts 42 
4. Difficulty in following patients  43 
5. Cost of staff education  44 
6. Consequences of screening 45 
7. The lack of recognition of other contributory factors in the use of and abstention from 46 
alcohol 47 
 48 
 While flexibility is an asset of SBIRT, numerous questions have been raised by the many 49 
studies conducted with variations to the interpretation of the SBIRT components.  For example, 50 
it is still unclear how variations in the screening and brief intervention process might affect  51 
validity of the screening and its results: would patients be more inclined to self-report accurate 52 
alcohol use if the screening is done within a larger health assessment by a physician versus a 53 
separate “survey” by a non-physician? Does it matter if brief intervention is conducted at 54 
screening or in a separate appointment with another provider? Do the variations explain the lack 55 
of long-term efficacy of SBIRT identified? Another challenge identified is assuring staff training 56 
and buy-in of screening SBIRT. 4,6-7  The results of motivational interviewing depend on who 57 
does it and how it is done. Do discriminative views of “alcoholics” wasting precious emergency 58 
room time affect screener’s interactions with patients? The challenge of tracking patients and 59 
attrition is also acknowledged by most authors contributing to the decreasing sample size as 60 
studies progressed.7-9,11 The usefulness of SBIRT may be in “closed” integrated systems where 61 
electronic health records are shared and accessible across provider groups and referral sites.   62 
Beyond the issues above, there is the concern of cost. In the environment of scarcity facing the 63 
U.S. health care system, who is to provide the training of staff, and who is to fund the long-term aspects 64 
of SBIRT to collect and analyze data, and to conduct follow-up interviews?  If and when a patient is ready 65 
for treatment, is there a place readily accessible or will a long waiting period diminish the readiness of the 66 
patient to comply with recommended follow-up?  67 
The final challenge of SBIRT is that it is  not intended to address the wide spectrum of causes of 68 
alcohol use nor the many factors that contribute to sobriety. There is much to be learned on the 69 
pathophysiology of alcohol use, on the psychological aspects of addictive behaviors and personal 70 
readiness to change, and why certain cultures are more prone to the misuse of alcohol. Complex 71 
multivariate analysis within SBIRT has yet to include biological and social factors such as family history 72 
of drinking; supportive relationships/family life; state of employment; and other stresses or support 73 
systems contributing to the use of or abstinence from alcohol.   74 
Clinical implications: to SBIRT or not to SBIRT 75 
 There are clearly concerns facing the implementation of SBIRT: mainly, its lack of long-76 
term efficacy  and uncertainty regarding realization of projectedcost savings across different 77 
provider groups . In light of the U.S. health care situation of sky-rocketing costs, should SBIRT 78 
be universally implemented in emergency departments while long-term efficacy studies are still 79 
being conducted? Will future studies show that, “brief” interventions have limited success for 80 
patients with high-risk alcohol use, and further assessment and treatment are actually needed? 81 
The other ethical concern is accessibility to treatment—is it harmful to screen, raise hopes for 82 
treatment, and deny that hope when treatment is not available?  Should funding target the causes 83 
of alcohol misuse, or be shifted to making treatment more available? 84 
 Contrary to these challenges are the positive public health aspects that can come from 85 
universal screening and learning the patterns of alcohol use within communities. The 86 
significance of preventive screening cannot be overstated in the management of any disease–and, 87 
there are many routine preventive services that have much less supporting evidence than SBIRT. 88 
We do know that an upstream high-risk screening early can prevent a critical trauma or chronic 89 
liver disease costing millions of dollars downstream.   90 
 The intentions of SBIRT are worthy but the long-term picture is incomplete. The decision 91 
to implement SBIRT must be carefully considered within the context of the overall burden of 92 
care due to alcohol-related injury and illness, the community needs assessment, and the resources 93 
available.  The results of long-term studies will be a welcomed addition to help decide if SBIRT 94 
is suitable for every emergency department. In the meantime, those emergency departments 95 
already implementing SBIRT will also help contribute to that body of knowledge. 96 
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